Genomic Subtype Of A Tumor May Contribute To Level Of ctDNA Shedding In Patients With Advanced NSCLC, Retrospective Study Indicates

January 20, 2021

Cancer Therapy Advisor (1/19, Bennett) reports researchers found in a retrospective study that “the genomic subtype of a tumor may contribute to the level of circulating tumor DNA (ctDNA) shedding in patients with advanced non–small cell lung cancer (NSCL...